Muhammad Mohiuddin Transplant trailblazer

Over the past decade, however, advances in gene-editing technology have allowed researchers to remove specific pig proteins and sugars that trigger the human immune system, making the organs more compatible. Like many other scientists, Mohiuddin had applied to the US Food and Drug Administration (FD...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) Vol. 612; no. 7941; p. 623
Main Author: Reardon, Sara
Format: Journal Article
Language:English
Published: London Nature Publishing Group 22-12-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over the past decade, however, advances in gene-editing technology have allowed researchers to remove specific pig proteins and sugars that trigger the human immune system, making the organs more compatible. Like many other scientists, Mohiuddin had applied to the US Food and Drug Administration (FDA) for permission to test xenotransplantation in a clinical trial. [...]on New Year's Eve, the FDA approved the emergency procedure and the team scheduled the surgery for 7January.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-022-04185-3